The Expression of CD14+CD16+ Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome
Figure 3
The protein level of CD14+CD16+ monocyte subpopulation in CHD patients with BSS by FACS analysis. (a) Representation data of FACS analysis of CD14+CD16+ monocyte subpopulation. Whole peripheral blood samples from patients and healthy individuals were stained with FITC-conjugated anti-CD14 antibody and PE-conjugated anti-CD16 antibody, followed by FACS. (b) The percentage of CD14+CD16+ monocoyte subpopulation in the whole CD14-positive cells. Results were presented as mean ± SD.
